1. Some manufacturers reported inaccurate drug product data to CMS Publication: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2020 Subject(s): Data AccuracyDrug Industry -- legislation & jurisprudenceGovernment RegulationMedicare Part B -- economicsPharmaceutical Preparations -- economicsUnited StatesUnited States. Department of Health and Human Services